New Study, Pharmaceutical Companies Losing Billions After States Legalize Cannabis

The legalization of cannabis has had a significant effect on pharmaceutical companies. A new study research project titled “U.S. Cannabis Laws Projected to Cost Generic, and Brand Pharmaceutical Firms Billions” used CRSP US Stock North America Daily Update, a third-party dataset, found that, since 1996, when legalizations began in the U.S states for both generic and brand-name drugs